Tags

Type your tag names separated by a space and hit enter

Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
Exp Ther Med. 2020 Sep; 20(3):2344-2347.ET

Abstract

In 2020 a new pandemic caused by the SARS-CoV-2 coronavirus is affecting the lives of millions of patients and healthcare workers worldwide. The clinical picture of this infection is in a dynamic process of discovery, and more symptoms emerge as the clinicians observe and diagnose manifestations that affect multiple organs. Anosmia (loss of smell), and ageusia (loss of taste) become more frequently cited as independent symptoms or in association with the most common manifestations of the disease, such as fever, cough and dyspnea. A thorough screening program will prevent most nosocomial and community-acquired infections by promoting efficient triage and specific measures such as isolation of the patients. Therefore, it is important to include frequent symptoms in the anamnesis and questionnaires to select those patients who might benefit from testing, isolation, and treatment. This study summarizes the existing data regarding the association of anosmia and ageusia with the SARS-CoV-2 infection. It also aims to describe manifestations of these, particularly in the clinical picture of all symptomatic patients.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.Department of Infectious Diseases, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.Department of Obstetrics and Gynecology, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.Department of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32765712

Citation

Tanasa, Ingrid Andrada, et al. "Anosmia and Ageusia Associated With Coronavirus Infection (COVID-19) - what Is Known?" Experimental and Therapeutic Medicine, vol. 20, no. 3, 2020, pp. 2344-2347.
Tanasa IA, Manciuc C, Carauleanu A, et al. Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known? Experimental and therapeutic medicine. 2020;20(3):2344-2347.
Tanasa, I. A., Manciuc, C., Carauleanu, A., Navolan, D. B., Bohiltea, R. E., & Nemescu, D. (2020). Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known? Experimental and Therapeutic Medicine, 20(3), 2344-2347. https://doi.org/10.3892/etm.2020.8808
Tanasa IA, et al. Anosmia and Ageusia Associated With Coronavirus Infection (COVID-19) - what Is Known. Experimental and therapeutic medicine. 2020;20(3):2344-2347. PubMed PMID: 32765712.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known? AU - Tanasa,Ingrid Andrada, AU - Manciuc,Carmen, AU - Carauleanu,Alexandru, AU - Navolan,Dan Bogdan, AU - Bohiltea,Roxana Elena, AU - Nemescu,Dragos, Y1 - 2020/05/28/ PY - 2020/04/27/received PY - 2020/05/28/accepted PY - 2020/8/9/entrez PY - 2020/8/9/pubmed PY - 2020/8/9/medline KW - COVID-19 KW - SARS-CoV-2 KW - ageusia KW - anosmia KW - coronavirus SP - 2344 EP - 2347 JF - Experimental and therapeutic medicine VL - 20 IS - 3 N2 - In 2020 a new pandemic caused by the SARS-CoV-2 coronavirus is affecting the lives of millions of patients and healthcare workers worldwide. The clinical picture of this infection is in a dynamic process of discovery, and more symptoms emerge as the clinicians observe and diagnose manifestations that affect multiple organs. Anosmia (loss of smell), and ageusia (loss of taste) become more frequently cited as independent symptoms or in association with the most common manifestations of the disease, such as fever, cough and dyspnea. A thorough screening program will prevent most nosocomial and community-acquired infections by promoting efficient triage and specific measures such as isolation of the patients. Therefore, it is important to include frequent symptoms in the anamnesis and questionnaires to select those patients who might benefit from testing, isolation, and treatment. This study summarizes the existing data regarding the association of anosmia and ageusia with the SARS-CoV-2 infection. It also aims to describe manifestations of these, particularly in the clinical picture of all symptomatic patients. SN - 1792-0981 UR - https://www.unboundmedicine.com/medline/citation/32765712/Anosmia_and_ageusia_associated_with_coronavirus_infection__COVID_19____what_is_known L2 - https://www.ingentaconnect.com/openurl?genre=article&issn=1792-0981&volume=20&issue=3&spage=2344&aulast=Tanasa DB - PRIME DP - Unbound Medicine ER -